Health In Tech (HIT) investor relations material

Executive summary

• Q3 2025 revenue was $8.5M, up 90% year-over-year; nine-month revenue reached $25.8M, surpassing 2024’s full-year total and representing 132% of last year's revenue.

• Adjusted EBITDA for Q3 was $1.0M, up 49% year-over-year; nine-month adjusted EBITDA totaled $3.8M, 167% of 2024’s total.

• Net income for Q3 was $452K, with nine-month net income at $1.58M; pre-tax income for nine months was $2.1M, 2.4x 2024’s full-year figure.

• Expanded distribution to 849 partners and 910 business clients, with billed-enrolled employees rising to 25,248, up 7,654 year-over-year.

• Launched large employer underwriting on eDIBS/eDIYBS, enabling bindable quotes for groups of 150+ employees in two weeks.

Financial highlights

• Gross margin for Q3 was 60.6%, down from 78.0% in Q3 2024; nine-month gross margin was 65.1%, down from 79.8%.

• Cash and cash equivalents as of September 30, 2025, were $8.0M; accounts receivable was $0.87M.

• Operating expenses for Q3 were $4.65M, including $962,567 in sales and marketing, $3.45M in G&A, and $235,819 in R&D.

• Cost of revenues increased to $9.0M (34.9% of revenue) for nine months, up from $2.9M (20.2% of revenue) in 2024.

• Total liabilities increased to $5.6M, and stockholders' equity rose to $17.2M as of September 30, 2025.

Outlook and guidance

• Q4 revenue growth expected at ~50% year-over-year, with full-year 2025 revenue projected at $32–$33M, ~70% year-over-year growth.

• Net income growth expected near 90% for 2025.

• Plans to launch blockchain-powered HITChain platform with AlphaTON Capital and resume HI Card development in late 2025 or early 2026.

• Focus on automation, operational efficiency, and scaling for larger employer groups.

• Anticipates continued strong growth into 2026, with major product launches and expanded market activities.